Screening for carriage of Staphylococcus aureus prior to mammary reconstruction in the prevention of surgical site infection

Annales de chirurgie plastique et esthétique
S RouquetteC Bendavid

Abstract

The incidence of prosthesis infections after breast reconstruction is of the order of 4% to 13% according to the literature. In surgical patients, Staphylococcus aureus (S. aureus) is the bacterial species most often responsible for surgical site infections. In cardiac surgery, screening for carriage of S. aureus and preoperative decontamination are carried out routinely before prosthetic surgery. We retrospectively reviewed data from patients at our institution between January 2011 and December 2013. Our series showed that the prosthesis infection rates were in the range of 5.92% in 2008 with an ISO rate of S. aureus 3.61%. Routine screening for prosthetic reconstructions was performed to assess the impact of preoperative decontamination patients in carriers of S. aureus. This screening was done in 381 patients: 17.8% of patients were carriers of S. aureus ; 11 patients have an ISO (or an incidence rate of 2.88%) ; 5 patients have an ISO S. aureus (an incidence of S. aureus ISO 1.3%). The introduction of the screening process, allowed a drop of 5.92% ISO rate at 1.46% with a passage of S. aureus SSI rates of 3, 60% to 0.72%. In the near future, studies are needed to confirm these encouraging results, to demonstrate the efficac...Continue Reading

References

Jan 1, 1995·The Journal of Infectious Diseases·J A KluytmansH A Verbrugh
May 24, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M D KalmeijerG A de Baere
Jun 14, 2002·The New England Journal of Medicine·Trish M PerlUNKNOWN Mupirocin And The Risk Of Staphylococcus Aureus Study Team
Aug 6, 2003·Plastic and Reconstructive Surgery·Maurice Y NahabedianPaul N Manson
Nov 29, 2005·The Lancet Infectious Diseases·Heiman F L WertheimJan L Nouwen
Aug 26, 2006·The Journal of Hospital Infection·A KonvalinkaI W Fong
Apr 26, 2008·BMJ : British Medical Journal·Gordon H GuyattUNKNOWN GRADE Working Group
Aug 9, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D S ActonA van Belkum
Oct 6, 2009·American Journal of Surgery·Rita A MukhtarE Shelley Hwang
Jan 8, 2010·The New England Journal of Medicine·Lonneke G M BodeMargreet C Vos
Aug 21, 2010·Annales de chirurgie plastique et esthétique·J QuilichiniP Le Masurier
Sep 13, 2011·Annales de chirurgie plastique et esthétique·M-C MissanaM Germain
Sep 12, 2012·Annals of Plastic Surgery·Randall O CraftAmy S Colwell
Aug 31, 2013·Médecine et maladies infectieuses·D LepelletierP Despins
Dec 7, 2013·Expert Review of Anti-infective Therapy·Paul O VerhoevenPhilippe Berthelot
Dec 18, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·George M ViolaKenneth V Rolston

❮ Previous
Next ❯

Citations

Aug 20, 2019·Annales de chirurgie plastique et esthétique·S de Mortillet
May 7, 2020·Orthopaedics & Traumatology, Surgery & Research : OTSR·Benjamin BouyerPierre Guigui

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Renato FinkelsteinSimcha Milo
Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología
Rubén Carvajal, Angela Londoño
© 2021 Meta ULC. All rights reserved